Search research articles
Contact Us
Filters
Showing results (171-180 of 272) with videos related to
Page
of 28
Sort By:
Acta Medica Okayama
|
August 24, 2016
The Efficacy of Rituximab in High-risk Renal Transplant Recipients
Motoo Araki, Koichiro Wada, Yosuke Mitsui, et al.
BMJ Open
|
September 10, 2020
Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease
Takaomi Kessoku, Takashi Kobayashi, Anna Ozaki, et al.
Journal of Hepatology
|
July 15, 2009
Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease
Yuichi Nozaki, Koji Fujita, Masato Yoneda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 12, 2012
Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: A multi-center validation study
Kento Imajo, Koji Fujita, Masato Yoneda, et al.
Plos One
|
June 14, 2013
Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis
Yuji Ogawa, Kento Imajo, Masato Yoneda, et al.
Journal of Pharmacological Sciences
|
April 9, 2008
Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway
Toshio Fujisawa, Atsushi Nakajima, Nobutaka Fujisawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 4, 2021
Guidelines for Infection Control in the Urological Field, including Urinary Tract Management (revised second edition)
Satoshi Takahashi, Soichi Arakawa, Kiyohito Ishikawa, et al.
Scientific Reports
|
December 10, 2021
A prospective interventional trial on the effect of periodontal treatment on Fusobacterium nucleatum abundance in patients with colorectal tumours
Tsutomu Yoshihara, Mitomu Kioi, Junichi Baba, et al.
Hepatology Communications
|
October 30, 2023
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease
Michihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.
International Journal of Clinical Oncology
|
June 5, 2021
Comparison of intracorporeal versus extracorporeal urinary diversion after robot-assisted radical cystectomy at a medium-sized facility
Takehiro Iwata, Yasuyuki Kobayashi, Yuki Maruyama, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 272) with videos related to
Sort By:
Page
of 28
Acta Medica Okayama
|
August 24, 2016
The Efficacy of Rituximab in High-risk Renal Transplant Recipients
Motoo Araki, Koichiro Wada, Yosuke Mitsui, et al.
BMJ Open
|
September 10, 2020
Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease
Takaomi Kessoku, Takashi Kobayashi, Anna Ozaki, et al.
Journal of Hepatology
|
July 15, 2009
Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease
Yuichi Nozaki, Koji Fujita, Masato Yoneda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 12, 2012
Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: A multi-center validation study
Kento Imajo, Koji Fujita, Masato Yoneda, et al.
Plos One
|
June 14, 2013
Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis
Yuji Ogawa, Kento Imajo, Masato Yoneda, et al.
Journal of Pharmacological Sciences
|
April 9, 2008
Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway
Toshio Fujisawa, Atsushi Nakajima, Nobutaka Fujisawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 4, 2021
Guidelines for Infection Control in the Urological Field, including Urinary Tract Management (revised second edition)
Satoshi Takahashi, Soichi Arakawa, Kiyohito Ishikawa, et al.
Scientific Reports
|
December 10, 2021
A prospective interventional trial on the effect of periodontal treatment on Fusobacterium nucleatum abundance in patients with colorectal tumours
Tsutomu Yoshihara, Mitomu Kioi, Junichi Baba, et al.
Hepatology Communications
|
October 30, 2023
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease
Michihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.
International Journal of Clinical Oncology
|
June 5, 2021
Comparison of intracorporeal versus extracorporeal urinary diversion after robot-assisted radical cystectomy at a medium-sized facility
Takehiro Iwata, Yasuyuki Kobayashi, Yuki Maruyama, et al.
Page
of 28